Angela Saxena
Obstetrics & Gynecology · Frankfort, KYNPI 1275516965
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.2% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 27.1% of the total. Reporting peaked in 2022 at $529 and has fallen 55.9% since, to $233 in 2025.
Across 121 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$640
- Bayer$315
- Astellas Pharma US Inc$308
- Hologic Sales And Service, LLC$167
- Pfizer$116
- Myovant Sciences Inc.$80
- plus $731 from 22 others
What the payments were for
- Food & beverage$2,17392%
- Education$1858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $640 |
| Bayer | 20 | $315 |
| Astellas Pharma US Inc | 9 | $308 |
| Hologic Sales And Service, LLC | 6 | $167 |
| Pfizer | 7 | $116 |
| Myovant Sciences Inc. | 4 | $80 |
| Sumitomo Pharma America, Inc. | 4 | $77 |
| Avion Pharmaceuticals | 5 | $67 |
| Mayne Pharma Commercial LLC | 5 | $63 |
| Biogen | 3 | $59 |
| Evofem Biosciences, Inc. | 4 | $56 |
| Exeltis, USA Inc. | 4 | $55 |
| Organon | 3 | $51 |
| Agile Therapeutics, Inc. | 3 | $44 |
| Abiomed | 1 | $44 |
| Amgen | 2 | $29 |
| Smith+Nephew | 1 | $24 |
| Mylan Pharmaceuticals Inc. | 1 | $22 |
| GSK | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $15 |
| Millicent US Inc | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Coopersurgical, Inc. | 1 | $14 |
| Exact Sciences | 1 | $13 |
| Meditrina | 1 | $12 |
| Merck | 1 | $12 |
How this compares
$2,358 in reported general payments places this provider in the 75th percentile of 474 obstetrics & gynecology providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 58 | $4,863 |
| Clobetasol Propionate | 16 | $520 |
| Nystatin | 12 | $141 |
| ValacyclovirValacyclovir Hcl | 11 | $120 |
| Fluconazole | 25 | $82 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Frankfort
- Mark WainwrightFrankfort$16K
- Connie WhiteFrankfort$5K
- Nikolina JonahFrankfort$5K
- Nathan SticeBowling Green$199K
- John BrunerSomerset$82K
- Resad PasicLouisville$39K
- Wendy JacksonLexington$37K
- Bradley YoukilisLouisville$29K
- Travis GilbertCorbin$28K
- James GuilerLexington$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.